Susceptibility to allergies were reduced by an increased production of regulatory T cells, according to a study conducted at the Institute of Immunology at MedUni Vienna.
Researchers used a new type of animal model to show that one's vulnerability to allergies declined when the activity of regulatory T cells went up.
The production of regulatory T cells was increased by combining the T-cell growth factor Interleukin-2 and an anti-Interleukin-2 antibody. The findings could help create preventative treatments for high-risk patients in the future.
The initial results of the study will be presented at the European Congress of Immunology in Vienna from September 6-9.
New study offers hope to allergy sufferers
Susceptibility to allergies were reduced by an increased production of regulatory T cells, according to a study conducted at the Institute of Immunology at MedUni Vienna.
Researchers used a new type of animal model to show that one's vulnerability to allergies declined when the activity of regulatory T cells went up.
The production of regulatory T cells was increased by combining the T-cell growth factor Interleukin-2 and an anti-Interleukin-2 antibody. The findings could help create preventative treatments for high-risk patients in the future.
The initial results of the study will be presented at the European Congress of Immunology in Vienna from September 6-9.
Would you like to comment on this article?
Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Trending
Latest Videos